1. Home
  2. BNZI vs SNOA Comparison

BNZI vs SNOA Comparison

Compare BNZI & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$3.49

Market Cap

5.7M

Sector

N/A

ML Signal

HOLD

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

BUY

Current Price

$1.18

Market Cap

6.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BNZI
SNOA
Founded
2016
1999
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
6.1M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
BNZI
SNOA
Price
$3.49
$1.18
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$24.00
N/A
AVG Volume (30 Days)
1.7M
119.0K
Earning Date
05-14-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,288,000.00
Revenue This Year
$41.28
$23.00
Revenue Next Year
$0.92
$24.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.19
52 Week Low
$0.20
$0.85
52 Week High
$8.10
$6.92

Technical Indicators

Market Signals
Indicator
BNZI
SNOA
Relative Strength Index (RSI) 52.00 42.46
Support Level $0.84 $1.00
Resistance Level $3.51 $1.23
Average True Range (ATR) 1.06 0.06
MACD -0.22 0.05
Stochastic Oscillator 5.56 90.00

Price Performance

Historical Comparison
BNZI
SNOA

About BNZI Banzai International Inc.

Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: